UBE2C promotes malignancy of cutaneous squamous cell carcinoma

BACKGROUND: Our study aimed to study the involvement of ubiquitin‐conjugating enzyme E2C (UBE2C) in cutaneous squamous cell carcinoma (cSCC). As the second most common malignancy with a rising incidence, understanding the molecular mechanisms driving cSCC is crucial for improved diagnosis and treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ruiting, Bai, Ruimin, Guo, Jiaqi, Xian, Ningyi, Zheng, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654470/
https://www.ncbi.nlm.nih.gov/pubmed/38009019
http://dx.doi.org/10.1111/srt.13526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654470/
https://www.ncbi.nlm.nih.gov/pubmed/38009019
http://dx.doi.org/10.1111/srt.13526

Ejemplares similares